Skip to main content
Smart Investors Daily
ES

OTC · ESLOY

EssilorLuxottica S.A.

Healthcare · Medical - Instruments & Supplies

$86.76

Down-$2.42 (-2.71%)

Updated Sep 4, 2026, 2:03 PM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
152.72B
P/E ratio
54.42
Dividend yield
2.60%
52-week range
— – —
Volume
7.9K
Avg. volume
53.93K

Price performance

ESLOY price history

1M range · 0 trading sessions · Daily adjusted prices

ESLOY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ESLOY news

The latest Smart Investors Daily articles mentioning ESLOY.

ESLOY research

Overview

Company profile and research snapshot.

Company profile

ESSILOR LXTTCA UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
Implied upside
Analysts
11
ESLOY recent ratings
DateFirmRatingTarget
Jul 13, 2026ROTHSCHILD & CO REDBURNBuy
Jul 12, 2026DAY BY DAYSell
Jul 7, 2026EQUITA SIMBuy
Jul 5, 2026STIFEL EUROPEBuy
Jun 30, 2026INTESA SANPAOLO EQUITY RESEARCHBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 12, 2026

National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter

By Karen Roman National Vision Holdings, Inc. (Nasdaq: EYE) said second quarter net revenue increased 2.5% to $498.8 million compared to the year prior and net income was $12.4 million against $8.7 million, with net income margin up to 2.5% from 1.8%. Diluted earnings per share were $0.15 compared to $0.11, and adjusted operating income […] The post National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter appeared first on ExecEdge.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.